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A new sporadic case of early-onset Loeys-Dietz syndrome due to
the recurrent mutation p.R528C in the TGFBR2 gene
substantiates interindividual clinical variability
Abstract
We report on a 2-year-old Polish girl with typical manifestations of Loeys-Dietz syndrome (LDS), a rare
genetic condition belonging to the group of marfanoid-habitus disorders. The characteristic LDS
symptoms observed in the presented girl included craniofacial dysmorphism (craniosynostosis, cleft
palate, hypertelorism), arachnodactyly, camptodactyly, scoliosis, joint laxity, talipes equinovarus,
translucent and hyperelastic skin, and umbilical hernia. Mild dilatation of the ascending aorta and
tortuous course of the left internal carotid artery were recognized during her second year of life.
Molecular genetic testing revealed a heterozygous missense mutation (c.1582C>T, p.R528C) in the
transforming growth factor beta receptor II gene (TGFBR2). This mutation has been previously
associated with LDS in five unrelated cases, and was never reported in the patients with other
marfanoid-habitus disorders. Comparison of the phenotypes of our patient and these five individuals
with c.1582C>T showed that only the hallmark triad of the syndrome consisting of hypertelorism, aortic
root dilatation/aneurysm, and cleft palate or bifid uvula was present in all six cases. Interestingly, none
of the five individuals who underwent psychological evaluation showed developmental delay. The
pattern of all other LDS features showed interindividual variability. Our data support the recently
reported observation that symptoms of LDS can develop at very young age, making early diagnosis and
management essential for these patients. This is the first report on the Polish infant with typical LDS
symptoms caused by a TGFBR2 mutation.
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ABSTRACT 
We report on a 2-year-old Polish girl with typical manifestations of Loeys-Dietz 
syndrome (LDS), a rare genetic condition belonging to the group of marfanoid-habitus 
disorders. The characteristic LDS symptoms observed in the presented girl included 
craniofacial dysmorphism (craniosynostosis, cleft palate, hypertelorism), arachnodactyly, 
camptodactyly, scoliosis, joint laxity, talipes equinovarus, translucent and hyperelastic skin, 
and umbilical hernia. Mild dilatation of the ascending aorta and tortuous course of the left 
internal carotid artery were recognized during her second year of life. Molecular genetic 
testing revealed a heterozygous missense mutation (c.1582C>T, p.R528C) in the transforming 
growth factor beta receptor II gene (TGFBR2). This mutation has been previously associated 
with LDS in five unrelated cases, and was never reported in the patients with other marfanoid-
habitus disorders. Comparison of the phenotypes of our patient and these five individuals with 
c.1582C>T showed that only the hallmark triad of the syndrome consisting of hypertelorism, 
aortic root dilatation/aneurysm, and cleft palate or bifid uvula was present in all six cases. 
Interestingly, none of the five individuals who underwent psychological evaluation showed 
developmental delay. The pattern of all other LDS features showed interindividual variability. 
Our data support the recently reported observation that symptoms of LDS can develop at very 
young age, making early diagnosis and management essential for these patients. This is the 
first report on the Polish infant with typical LDS symptoms caused by a TGFBR2 mutation.  
 
Key words: Loeys-Dietz syndrome, marfanoid-habitus disorder, TGFBR1, TGFBR2, 
missense mutation, arterial tortuosity  
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INTRODUCTION 
 Loeys-Dietz syndrome (LDS) is a recently characterized autosomal-dominant genetic 
condition belonging to the marfanoid-habitus disorders, a subset of connective tissue diseases 
with skeletal, ocular, and cardiovascular involvement. The initial report on LDS appeared in 
2005 by Loeys et al. (2005). The authors characterized ten families of the syndrome and 
found heterozygous mutations in the genes encoding transforming growth factor beta receptor 
I (TGFBR1) or II (TGFBR2). In 2006, Loeys et al. (2006) described 30 additional individuals 
with the diagnosis of typical LDS. Nearly all patients presented with a triad of symptoms 
comprising arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate, 
and all harboured a TGFBR1 or a TGFBR2 heterozygous mutation. In addition, in the same 
work Loeys et al. (2006) studied a cohort of 40 patients with a vascular Ehlers-Danlos 
syndrome-like (EDS IV) phenotype without characteristic collagen type III (COL3A1) 
anomalies or craniofacial dysmorphism typical of LDS, and identified heterozygous mutations 
either in TGFBR1 or TGFBR2 in 12 probands. LDS type I was proposed to stand for the 
syndrome with typical facial dysmorphic features, and LDS type II to describe the syndrome 
without craniofacial affectation. Both entities are characterized by aggressive arterial 
aneurysms (Loeys et al. 2006). Occasional findings in LDS type I encompass 
craniosynostosis, congenital heart defect, structural brain abnormality, hydrocephaly, and 
mental retardation/developmental delay (Loeys et al. 2005; 2006; Stheneur et al. 2008). In 
order to distinguish between the genetic background of LDS type I and type II, additional 
nomenclature subdivides cases into subtype A resulting from TGFBR1 mutations, and subtype 
B caused by TGFBR2 mutations (Loeys et al. 2006). Currently, with growing number of LDS 
patients, a detailed clinical phenotype of the syndrome is beginning to emerge.  
In this report, we describe a Polish girl with typical LDS type I caused by recurrent 
TGFBR2 mutation (p.R528C). We refer her clinical picture to the phenotype of five other 
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LDS cases resulting from the same mutation, and to the total of LDS type I population 
reported to date in the literature.  
CASE REPORT 
  The proband, a 2-year-old girl of Polish descent, was born by elective Caesarean 
section after uneventful pregnancy (G2P2) at 39 weeks of gestation to a nonconsanguineous 
and healthy 30-year-old mother and a 33-year-old father. At birth, her weight was 2800 g 
(10th-25th centile), length 51 cm (75th-90th centile), head circumference 34 cm (50th 
centile), and Apgar score was 10 at 1, 3, and 5 minutes, respectively. Physical examination 
after birth showed craniofacial dysmorphism with prominent forehead, cleft soft and hard 
palate, and long slender fingers. An ultrasound scan of the brain at 3 months revealed external 
hydrocephaly and 8 mm in diameter subependymal cyst of the right lateral ventricle. On 
repeated ultrasound brain controls, mild dilatation of the lateral ventricles, with gradually 
decreasing external hydrocephaly were noted. Hearing tests performed at the age of 8 months 
showed initially right-sided and subsequently bilateral conductive hypoacusis. The girl was 
referred to our genetic clinic for diagnosis and first investigated at the age of 9 months. Upon 
examination, she presented with craniofacial dysmorphic features comprising scaphocephalic 
shape of the head with frontal bossing due to craniosynostosis (premature closure of sagittal 
suture), proptosis, hypertelorism, mild epicanthal folds, blue sclerae, short nose with flat nasal 
bridge, micrognathia, cleft hard and soft palate, and thin upper lip (Figs. 1a, b, c, d). Her 
length and head circumference was 65 cm (<3rd percentile) and 45 cm (50th-75th percentile), 
respectively. Enlarged, prominent anterior fontanelle and widening of subcutaneous veins on 
the skull were conspicuous (Fig. 1c). Furthermore, arachnodactyly of the hands and feet, 
camptodactyly of the V-th fingers (Fig. 1e), joint laxity, hyperelastic translucent skin, and 
umbilical hernia were noted (Fig. 1a). Psychomotor development was apparently normal. 
Cardiac sonography at 16 months revealed a mild dilatation of the ascending aorta and a trace 
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patent foramen ovale (PFO) without haemodynamically significant interatrial shunting. The 
girl was re-investigated in the genetic clinic at 19 months of age. Dysmorphic features seen 
during her first evaluation were still present. Her growth was slightly retarded with 
measurements of 9.8 kg (<3rd percentile), 77.5 cm (3-10 percentile), and 48.5 cm (50-75 
percentile). According to anamnesis, developmental milestones were achieved on time, with 
independent sitting at 7, walking at 12, and expressive speech (several first words) at 12 
months. MRI of the brain showed no structural malformation, but magnetic resonance 
angiography of the brain vessels at 23 months of age disclosed abnormal pars cavernosa of the 
left internal carotid artery, described as most probable tortuous course of the artery, or less 
likely arterial aneurysm. Chromosomal analysis on peripheral blood lymphocytes with 
resolution of 550 bands per haploid genome revealed a normal female karyotype (46,XX). 
Except mild hypertelorism in the father, both parents had no signs of craniofacial 
dysmorphism. Family history was non-contributory.  
 To confirm our clinical diagnosis of LDS, we performed molecular genetic testing of 
the TGFBR1 and TGFBR2 genes (informed consent of the parents was obtained prior to 
genetic testing). All exons and flanking intronic regions of both genes were amplified and 
sequenced according to Matyas et al. (2006). In our proband, we detected a heterozygous 
substitution of C>T at position 1582 (c.1582C>T) in exon 7 (Fig. 2), resulting in a missense 
mutation at codon 528 in the C-terminal fragment of the TGFBR2 protein (p.R528C). The 
mutation affects a highly conserved amino acid residue (arginine) and was predicted to 
damage protein function (cf. Matyas et al. 2006). However, the possibility that c.1582C>T has 
an effect on mRNA expression or splicing cannot be excluded. Additionally, two known 
TGFBR2 polymorphisms, one homozygous for IVS2+7A>G (rs1155705) and the other 
heterozygous for IVS3-4T>A (rs11466512), were identified. Deletions/duplications of all 
TGFBR1 and TGFBR2 exons were excluded by multiplex ligation-dependent probe 
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amplification (MLPA) using the SALSA kits P065 and P148, as described elsewhere (Matyas 
et al. 2007). The mutation c.1582C>T was not detected in the leukocyte DNAs of the 
unaffected parents, but (germline) mosaicism cannot be excluded. Haplotype analysis using 
eight short tandem repeat markers on six different chromosomes confirmed paternity and thus 
de novo occurrence of c.1582C>T (p.R528C).  
DISCUSSION 
Loeys-Dietz syndrome is a rare genetic condition classified as marfanoid-habitus or 
MFS-related disorder. So far, a series of about 80 LDS patients have been described in the 
literature, with a majority of adult individuals (e.g. Loeys et al. 2005; 2006; Sakai et al. 2006; 
Singh et al. 2006; Matyas et al. 2006; Akutsu et al. 2007; Togashi et al. 2007; LeMaire et al. 
2007; Aalberts et al. 2008; Stheneur et al. 2008; Frederic et al. 2008). Clinical phenotype of 
LDS overlaps to some extent with Marfan syndrome, including the propensity for aortic 
aneurysm and dissection, and thus the condition may pose diagnostic difficulties, and still be 
lumped together with MFS (Ades et al. 2006). In addition to the phenotypic overlap, MFS and 
LDS share partially common genetic background. Besides the FBN1 mutations responsible 
for more than 90% of the cases, MFS with or without fulfilment of Ghent criteria, can be 
caused by mutations in the TGF receptor genes (Mizuguchi and Collod-Beroud et al. 2004; 
Disabella et al. 2006; Matyas et al. 2006; Singh et al. 2006; Stheneur et al. 2008). LDS is 
caused solely by TGFBR1 or TGFBR2 mutations, and as a result, seems to have a distinct 
natural history. With respect to MFS, the syndrome conveys a higher risk of arterial dissection 
without considerable dilatation of the affected vessel and is characterized by marked arterial 
tortuosity or aneurysms throughout the arterial tree. Furthermore, mean age of a deadly 
vascular episode without treatment is estimated at 26 years, which is at least a few years 
earlier than in MFS. Therefore, this is of great relevance to make a distinction between these 
two conditions. Early diagnosis is the prerequisite for adequate management of LDS patients. 
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Thorough repeated clinical assessment of the cardiovascular system (echocardiography, 
angiography, MRI angiography), along with aggressive surgical repair of aneurysms should 
be undertaken to prevent future vascular events (Yetman et al. 2007).  
Here, we present a female infant with typical manifestation of LDS type I, initially 
seen and evaluated by us at the age of 9 months. Mutational analysis of the TGFBR1 and 
TGFBR2 genes revealed a de novo TGFBR2 missense mutation (c.1582C>T, p.R528C). This 
mutation has been previously described in five unrelated LDS cases (Loeys et al. 2005; 2006; 
LeMaire et al. 2007; Stheneur et al. 2008). Interestingly, to our knowledge, the mutation has 
never been identified in the patients either with MFS or other MFS-related disorders 
(Shprintzen-Goldberg syndrome, thoracic aortic aneurysm and dissection) suggesting its 
specificity to LDS. Comparison of the phenotypes of all six individuals with c.1582C>T 
(p.R528C) showed that only the hallmark triad of the syndrome consisting of hypertelorism, 
aortic root dilatation/aneurysm, and cleft palate or bifid uvula was present in all the patients. 
The above features occur with the highest frequencies in overall LDS type I population, 
regardless the mutation. Interestingly, none of the five affected individuals who underwent 
psychological evaluation presented with psychomotor retardation. The overall incidence of 
developmental delay in a subset of 67 LDS type I patients was estimated to be about 10% 
(Table 1). Lack of this feature in the patients with p.R528C TGFBR2 mutation most probably 
results from a small number of individuals in our study. On the other hand, it is also possible 
that the mutation has little impact on neurocognitive development. The pattern of other LDS 
type I characteristics caused by the p.R528C TGFBR2 mutation showed more interindividual 
variability (Table 1).  
Although our patient was very young, she presented with mild aortic root dilatation 
and magnetic angiography of the brain vessels disclosed a corkscrew course (or aneurysm) of 
the left internal carotid artery. The reported case confirms that symptoms of LDS begin to 
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develop at young age and thus an early recognition that allows for appropriate management 
and treatment of these patients is needed (Loeys et al. 2005; Stheneur et al. 2008). Genetic 
testing of TGFBR1 and TGFBR2, especially in cases with mild or inconspicuous facial 
dysmorphism, should be regarded as the method of choice to verify tentative diagnosis of 
LDS.  
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Table 1. Overview of clinical features observed in patients with the TGFBR2 mutation p.R528C in respect of 
the overall LDS type I (LDS1) population.  
 
Loeys et 
al. 
(2005) 
Loeys et al. 
(2006) – 
case 1 
Loeys et al. 
(2006) – 
case 2* 
LeMaire et 
al. (2007) 
Stheneur et 
al. (2008) 
Our 
case 
Total of 
p.R528C 
TGFBR2
A total of up to 77 LDS1 
patients (according to 
the literature#) 
Craniofacial:         
Hypertelorism + + + + + + 6/6 48/74 (65%) 
Cleft 
palate/abnormal 
uvula 
+/+ +/+ –/+ –/+ –/+ +/– 6/6 
57/74 (77%) 
Malar hypoplasia + + – +  + – 4/6 38/64 (59%) 
Retrognathia – + – + – + 3/6 29/62 (47%) 
Craniosynostosis – – – – – + 1/6 22/73 (30%) 
Proptosis – – – – – + 1/6 ? 
Blue sclerae – + – – – + 2/6 23/64 (36%) 
Cardiovascular:         
Aortic root 
dilatation/aneurysm 
+ + + + + + 6/6 73/77 (95%) 
Arterial tortuosity + + + + – + 5/6 26/38 (68%) 
Aneurysm of other 
vessels 
PAA ? DAA Multiple 
aneurysms 
? ? 3/6-6/6 29/60 (48%) 
Congenital heart 
defect 
– – PDA – – PFO 2/6 ? 
Mitral valve 
prolapse 
+ – – – + – 2/6 6/28 (21%) 
Musculoskeletal:          
Dolichostenomelia – – – – + – 1/6  19/66 (29%) 
Arachnodactyly + + + – + + 5/6 37/66 (56%) 
Camptodactyly  + – – – – + 2/6 23/65 (35%) 
Talipes equinovarus – + + – – – 2/6 23/65 (35%) 
Joint laxity – + + + + + 5/6 44/66 (67%) 
Pectus deformity – + + + + – 2/6 42/66 (64%) 
Scoliosis – – + + + – 3/6 35/66 (53%) 
Umbilical/inguinal 
hernia 
? – + + – + 3/5-4/6 5/17 (29%) 
Skin:          
Velvety texture – + ? + – + 3/5-4/6 14/52 (27%) 
Translucency – + + + – + 4/6 18/52 (35%) 
Hyperelastic skin ? ? + – – + 2/4-4/6 ? 
Nervous system:         
Developmental 
delay 
– ** – – – – 0/5-1/6 7/67 (10%) 
Hydrocephalus – ? ? – – + 1/4-3/6 6/59 (10%) 
# Loeys et al. (2005, 2006); Sakai et al. (2006); Singh et al. (2006); Matyas et al. (2006); Akutsu et al. (2007); 
Togashi et al. (2007); LeMaire et al. (2007); Aalberts et al. (2008); Stheneur et al. (2008);  
* patient died at age 16, ** patient evaluated at the age of 6 months  
+/– indicate presence/absence of a feature  
? – no data available 
PAA – pulmonary artery aneurysm; DAA – Descending aorta aneurysm;  
PDA – patent ductus arteriosus; PFO – persistent foramen ovale  
Bolded numbers indicate features demonstrated in all or none of the analyzed patients  
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FIGURE LEGENDS 
 
Figure 1. The proband at the age of 9 months. A) A whole view picture of the proband 
showing prominent umbilical hernia. B) Facial dysmorphic features seen in the proband 
include hypertelorism, prominent forehead, short nose with flat nasal bridge, thin upper lip, 
and discrete epicanthal folds. C) Lateral view showing abnormal skull shape with frontal 
bossing, micrognathia, widened veins, and translucent skin on the head. D) Cleft soft and hard 
palate. E) Arachnodactyly of the hand with camptodactyly of the V-th finger.  
 
Figure 2. Partial forward sequence of the TGFBR2 gene (exon 7) flanking the mutation 
c.1582C>T (p.R528C) in our patient and her parents. Arrows indicate the site of mutation.  
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FIGURE 1A 
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FIGURE 1B 
 
 
 
 
 
 
 
 
FIGURE 1C 
 
 
 
 
 
 
 16 
FIGURE 1D 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1E 
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FIGURE 2 
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